Navigation Links
InSightec Treats First Prostate Cancer Patients in Clinical Trials
Date:8/30/2010

says Associate Professor Christopher Cheng, Head & Senior Consultant, Department of Urology Singapore General Hospital, Singapore.

In the prostate cancer therapy application the major expected benefits of the ExAblate treatment are:

- Low complication rate - Non-invasive treatment, patients back to their life within a day or two - Non-ionized radiation - Single session therapy - Real time MR thermometry monitoring that is used to control treatment outcome during treatment

"We are very pleased to have been the first facility to adopt the ExAblate system for Phase 1 prostate cancer clinical trials." said principle investigator Professor S.V. Kanaev, Chairman of Radiation Oncology, N.N Petrov Research Institute of Oncology. "We have had excellent results with ExAblate in treating patients suffering from bone metastases and we believe it has tremendous potential in treating prostate cancer patients with a low complication rate. We and our patients have been very pleased with the results achieved to date."

InSightec will shortly be expanding the prostate clinical trials to additional leading sites globally.

About InSightec

InSightec Ltd. is a privately-held company owned by Elbit Imaging, General Electric, MediTech Advisors, LLC and employees. It was founded in 1999 to develop the breakthrough MR guided Focused Ultrasound technology and transform it into the next generation operating room. Headquartered near Haifa, Israel, the company has over 160 employees and has invested more than $130 million in research, development, and clinical investigations. Its U.S. headquarters are located in Dallas, Texas. For more information, please go to: http://www.insightec.com/

About ExAblate(R)

ExAblate is an Image Guided, Non-invasive, Robotic Acoustic Surgery system. The ExAblate system is the first to use the MR guided focused ultrasound technology that combines MRI - to vi
'/>"/>

SOURCE InSightec Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. InSightec Ltd. Announces US$15 Million Investment Round
2. LF Elimination Program Treats Over Half Billion People and Protects Millions More From Debilitating Disease
3. DaVita Treats Thousands of Dialysis Patients in Wake of Hurricane Ike
4. CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries
5. bioserie Introduces the Worlds First Made of Plants iPhone 4 Cover
6. Range Fuels Produces Cellulosic Methanol From First Commercial Cellulosic Biofuels Plant
7. Imagenetix, Inc. Reports First Quarter 2011 Results
8. Forensic Laboratories Develops First Oral Fluid Test for Ethyl Sulfate Detection
9. Octapharma Grants Program Awards First Research Grant to Rush University Medical Center
10. China-Biotics to Report Fiscal Year 2011 First Quarter Financial Results on August 9
11. Beike Biotechnology Opens First Chinese Rehabilitation Center in Romania
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015   ... company, and Sequenom, Inc. (NASDAQ: SQNM ... a development agreement for next generation noninvasive prenatal ... Cypher,s genome interpretation technology, called Mantis™, to advance ...
(Date:1/22/2015)... 22, 2015  Derma Sciences, Inc. (Nasdaq: ... advanced wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, ... added to the Premier, Inc. Regenerative Skin Grafting ... the AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue ...
(Date:12/24/2014)... YORK , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. ... critical areas, announced the closing of an underwritten public offering ... up to an aggregate 3,500,000 shares of common stock, at ... warrant.  The warrants have a per share exercise price of ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market by ... Solvents, Buffers, Valves, Guages, Seals), Accessories, Services, End ... to 2019” provides a detailed overview of the ... and strategies impacting the preparative and process chromatography ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4
... Pharmaceuticals, Inc. (Nasdaq: ISTA ) today ... solution for dry eye) Phase 2 clinical study. ... endpoint of the objective sign of conjunctival staining ... achieved statistical significance on the objective sign of ...
... Results for Fourth Quarter Fiscal 2010 -- LAIYANG, China, Sept. 27 /PRNewswire-Asia-FirstCall/ -- ... ... (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, ...
... Pty. Ltd (Sydney, Australia) and The Garvan Institute ... they have entered into a license agreement in ... the Garvan Institute. Under the terms of the ... the Garvan,s proprietary cancer associated methylation DNA biomarkers ...
Cached Biology Technology:ISTA Pharmaceuticals Highlights Clinical Data from REMURA™ Phase 2 Study Presented at the 6th International Conference on the Tear Film & Ocular Surface 2ISTA Pharmaceuticals Highlights Clinical Data from REMURA™ Phase 2 Study Presented at the 6th International Conference on the Tear Film & Ocular Surface 3ISTA Pharmaceuticals Highlights Clinical Data from REMURA™ Phase 2 Study Presented at the 6th International Conference on the Tear Film & Ocular Surface 4Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 2Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 3Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 4Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 5Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 6Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 7Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement 2
(Date:12/17/2014)... and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) has announced ... Home Button Synaptics Fingerprint Sensor Technology Analysis" report ... Based on a totally different sensing ... first time a fingerprint sensor in its product. ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a leader in ... biometric technology to industry leaders such as Intel, Jabra, ... validated, biometric wearable products. These products will be showcased ... Las Vegas . "Our ...
(Date:12/15/2014)... and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) has announced ... 2015-2019" report to their offering. ... a technology used for the identification of individuals. Facial ... person such as nose, jaw edges, mouth, and the ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... its owner than a lost cat, according to two new studies. , ... of lost dogs were found, compared to just 53 percent of lost ... found by a call or visit to an animal shelter. More than ... license or identification tag at the time of its disappearance. , ...
... Medicine and Pharmacology at the University of California, San ... twin pairs over the past few years, which has ... many traits and genes, we have started to put ... variations in twins provides scientists with data on traits ...
... appears not to have extended to South American agriculture, ... , The University of Manchester researchers compared the DNA ... the mummy and at other sites in northwest Argentina ... , Surprisingly, they found both ancient and modern samples ...
Cached Biology News:Lost dogs found more often than lost cats, study suggests 2Lost dogs found more often than lost cats, study suggests 3Twin studies reveal genetic components leading to cardiac and kidney disease 2Twin studies reveal genetic components leading to cardiac and kidney disease 3
...
... purified recombinant human angiogenin expressed ... Physical form: Lyophilized from ... in phosphate buffered saline. ... WB. Titertest values: capture ...
Request Info...
2 ml SmartScan Racks...
Biology Products: